InHealth Intelligence is the largest provider of diabetic eye screening services in the UK, serving a cohort of over 1,000,000 people with diabetes and delivering services since 2011.
Diabetic eye screening is a key part of diabetes care. People with diabetes are at risk of damage from diabetic retinopathy, a condition that can lead to sight loss if it is not treated. This occurs when diabetes affects small blood vessels, damaging the back of the eye called the retina. Early identification and treatment of diabetic eye disease can reduce sight loss. Screening can detect the condition early before you notice any changes to your vision.
The NHS diabetic eye screening (DES) programme is one of the young person and adult NHS population screening programmes. The eligible population for DES is all people with type 1 and type 2 diabetes aged 12 or over who are called once a year for screening.